Vulnerabilities of mutant SWI/SNF complexes in cancer

Cancer Cell

Volumn 26, Issue 3, 2014, Pages 309-317

  Helming, Katherine C ^a,b,c   Wang, Xiaofeng ^a,b,c   Roberts, Charles W M ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC AGENT; BRG1 PROTEIN; BRM PROTEIN; BROMODOMAIN INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN SWI; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR SNF; UBIQUITIN PROTEIN LIGASE E3; MULTIPROTEIN COMPLEX; TRANSCRIPTION FACTOR;

BREAST CANCER; BURKITT LYMPHOMA; CANCER CELL; CANCER SUSCEPTIBILITY; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; COLON CANCER; COMPLEX FORMATION; ENDOMETRIOID CARCINOMA; GENE EXPRESSION; GENE MUTATION; HAPLOINSUFFICIENCY; HUMAN; KIDNEY CARCINOMA; LIVER CANCER; LIVER CELL CARCINOMA; LOSS OF FUNCTION MUTATION; LUNG CANCER; MEDULLOBLASTOMA; MELANOMA; MENINGIOMA; MISSENSE MUTATION; NEUROBLASTOMA; NONHUMAN; NUCLEOSOME; OVARY CANCER; PANCREAS CANCER; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RETINOBLASTOMA; REVIEW; RHABDOID TUMOR; SMALL CELL CARCINOMA; STOMACH CANCER; TRANSCRIPTION REGULATION; ANIMAL; GENETIC PREDISPOSITION; GENETICS; MOLECULARLY TARGETED THERAPY; MUTATION; NEOPLASM; PROTEIN SUBUNIT;

ANIMALS; ANTINEOPLASTIC AGENTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOLECULAR TARGETED THERAPY; MULTIPROTEIN COMPLEXES; MUTATION; NEOPLASMS; PROTEIN SUBUNITS; TRANSCRIPTION FACTORS;

EID: 84908693041     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2014.07.018     Document Type: Review

References (108)

1. Betz B.L., Strobeck M.W., Reisman D.N., Knudsen E.S., Weissman B.E. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene 2002, 21:5193-5203.
2. Biegel J.A., Zhou J.Y., Rorke L.B., Stenstrom C., Wainwright L.M., Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999, 59:74-79.
3. Bourachot B., Yaniv M., Muchardt C. The activity of mammalian brm/SNF2alpha is dependent on a high-mobility-group protein I/Y-like DNA binding domain. Mol. Cell. Biol. 1999, 19:3931-3939.
4. Bultman S.J., Herschkowitz J.I., Godfrey V., Gebuhr T.C., Yaniv M., Perou C.M., Magnuson T. Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene 2008, 27:460-468.
5. Buscarlet M., Krasteva V., Ho L., Simon C., Hébert J., Wilhelm B., Crabtree G.R., Sauvageau G., Thibault P., Lessard J.A. Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance. Blood 2014, 123:1720-1728.
6. Cheng S.W., Davies K.P., Yung E., Beltran R.J., Yu J., Kalpana G.V. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat. Genet. 1999, 22:102-105.
7. Cheung H.W., Cowley G.S., Weir B.A., Boehm J.S., Rusin S., Scott J.A., East A., Ali L.D., Lizotte P.H., Wong T.C., et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc. Natl. Acad. Sci. USA 2011, 108:12372-12377.
8. Chi T.H., Wan M., Zhao K., Taniuchi I., Chen L., Littman D.R., Crabtree G.R. Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. Nature 2002, 418:195-199.
9. Doan D.N., Veal T.M., Yan Z., Wang W., Jones S.N., Imbalzano A.N. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes. Oncogene 2004, 23:3462-3473.
10. Dunaief J.L., Strober B.E., Guha S., Khavari P.A., Ålin K., Luban J., Begemann M., Crabtree G.R., Goff S.P. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 1994, 79:119-130.
11. Dykhuizen E.C., Hargreaves D.C., Miller E.L., Cui K., Korshunov A., Kool M., Pfister S., Cho Y.-J., Zhao K., Crabtree G.R. BAF complexes facilitate decatenation of DNA by topoisomerase IIα. Nature 2013, 497:624-627.
12. Eroglu E., Burkard T.R., Jiang Y., Saini N., Homem C.C.F., Reichert H., Knoblich J.A. SWI/SNF complex prevents lineage reversion and induces temporal patterning in neural stem cells. Cell 2014, 156:1259-1273.
13. Filippakopoulos P., Qi J., Picaud S., Shen Y., Smith W.B., Fedorov O., Morse E.M., Keates T., Hickman T.T., Felletar I., et al. Selective inhibition of BET bromodomains. Nature 2010, 468:1067-1073.
14. Filippakopoulos P., Picaud S., Mangos M., Keates T., Lambert J.-P., Barsyte-Lovejoy D., Felletar I., Volkmer R., Müller S., Pawson T., et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 2012, 149:214-231.
15. Flowers S., Nagl N.G., Beck G.R., Moran E. Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. J. Biol. Chem. 2009, 284:10067-10075.
16. Fukuoka J., Fujii T., Shih J.H., Dracheva T., Meerzaman D., Player A., Hong K., Settnek S., Gupta A., Buetow K., et al. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin. Cancer Res. 2004, 10:4314-4324.
17. Gao X., Tate P., Hu P., Tjian R., Skarnes W.C., Wang Z. ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a. Proc. Natl. Acad. Sci. USA 2008, 105:6656-6661.
18. Glaros S., Cirrincione G.M., Muchardt C., Kleer C.G., Michael C.W., Reisman D. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. Oncogene 2007, 26:7058-7066.
19. Gong F., Fahy D., Smerdon M.J. Rad4-Rad23 interaction with SWI/SNF links ATP-dependent chromatin remodeling with nucleotide excision repair. Nat. Struct. Mol. Biol. 2006, 13:902-907.
20. Gresh L., Bourachot B., Reimann A., Guigas B., Fiette L., Garbay S., Muchardt C., Hue L., Pontoglio M., Yaniv M., Klochendler-Yeivin A. The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation. EMBO J. 2005, 24:3313-3324.
21. Gui Y., Guo G., Huang Y., Hu X., Tang A., Gao S., Wu R., Chen C., Li X., Zhou L., et al. Frequent mutations of chromatin remodeling genes intransitional cell carcinoma of the bladder. Nat. Genet. 2011, 43:875-878.
22. Guichard C., Amaddeo G., Imbeaud S., Ladeiro Y., Pelletier L., Maad I.B., Calderaro J., Bioulac-Sage P., Letexier M., Degos F., et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat. Genet. 2012, 44:694-698.
23. Guidi C.J., Sands A.T., Zambrowicz B.P., Turner T.K., Demers D.A., Webster W., Smith T.W., Imbalzano A.N., Jones S.N. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol. Cell. Biol. 2001, 21:3598-3603.
24. Halliday G.M., Zhou Y., Sou P.W., Huang X.X.J., Rana S., Bugeja M.J., Painter N., Scolyer R.A., Muchardt C., Di Girolamo N., Lyons J.G. The absence of Brm exacerbates photocarcinogenesis. Exp. Dermatol. 2012, 21:599-604.
25. Hara R., Sancar A. The SWI/SNF chromatin-remodeling factor stimulates repair by human excision nuclease in the mononucleosome core particle. Mol. Cell. Biol. 2002, 22:6779-6787.
26. Helming K.C., Wang X., Wilson B.G., Vazquez F., Haswell J.R., Manchester H.E., Kim Y., Kryukov G.V., Ghandi M., Aguirre A.J., et al. ARID1B is a specific vulnerability in ARID1A-mutant cancers. Nat. Med. 2014, 20:251-254.
27. Ho L., Jothi R., Ronan J.L., Cui K., Zhao K., Crabtree G.R. Anembryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc. Natl. Acad. Sci. USA 2009, 106:5187-5191.
28. Hodis E., Watson I.R., Kryukov G.V., Arold S.T., Imielinski M., Theurillat J.-P., Nickerson E., Auclair D., Li L., Place C., et al. A landscape of driver mutations in melanoma. Cell 2012, 150:251-263.
29. Hoffman G.R., Rahal R., Buxton F., Xiang K., McAllister G., Frias E., Bagdasarian L., Huber J., Lindeman A., Chen D., et al. Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers. Proc. Natl. Acad. Sci. USA 2014, 111:3128-3133.
30. Hu G., Schones D.E., Cui K., Ybarra R., Northrup D., Tang Q., Gattinoni L., Restifo N.P., Huang S., Zhao K. Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1. Genome Res. 2011, 21:1650-1658.
31. Isakoff M.S., Sansam C.G., Tamayo P., Subramanian A., Evans J.A., Fillmore C.M., Wang X., Biegel J.A., Pomeroy S.L., Mesirov J.P., et al. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proc. Natl. Acad. Sci. USA 2005, 102:17745-17750.
32. Jayaraman S.S., Rayhan D.J., Hazany S., Kolodney M.S. Mutational landscape of basal cell carcinomas by whole-exome sequencing. J. Invest. Dermatol. 2014, 134:213-220.
33. Jelinic P., Mueller J.J., Olvera N., Dao F., Scott S.N., Shah R., Gao J., Schultz N., Gonen M., Soslow R.A., et al. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. Nat. Genet. 2014, 46:424-426.
34. Jones S., Wang T.-L., Shih IeM., Mao T.-L., Nakayama K., Roden R., Glas R., Slamon D., Diaz L.A., Vogelstein B., et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010, 330:228-231.
35. Kadam S., Emerson B.M. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol. Cell 2003, 11:377-389.
36. Kadam S., McAlpine G.S., Phelan M.L., Kingston R.E., Jones K.A., Emerson B.M. Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev. 2000, 14:2441-2451.
37. Kadoch C., Crabtree G.R. Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma. Cell 2013, 153:71-85.
38. Kadoch C., Hargreaves D.C., Hodges C., Elias L., Ho L., Ranish J., Crabtree G.R. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat. Genet. 2013, 45:592-601.
39. Kassabov S.R., Zhang B., Persinger J., Bartholomew B. SWI/SNF unwraps, slides, and rewraps the nucleosome. Mol. Cell 2003, 11:391-403.
40. Kasten M.M., Clapier C.R., Cairns B.R. SnapShot: Chromatin remodeling: SWI/SNF. Cell 2011, 144:310.e1.
41. Kennison J.A., Tamkun J.W. Dosage-dependent modifiers of polycomb and antennapedia mutations in Drosophila. Proc. Natl. Acad. Sci. USA 1988, 85:8136-8140.
42. Kia S.K., Gorski M.M., Giannakopoulos S., Verrijzer C.P. SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Mol. Cell. Biol. 2008, 28:3457-3464.
43. Kim W., Bird G.H., Neff T., Guo G., Kerenyi M.A., Walensky L.D., Orkin S.H. Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer. Nat. Chem. Biol. 2013, 9:643-650.
44. Klochendler-Yeivin A., Fiette L., Barra J., Muchardt C., Babinet C., Yaniv M. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep. 2000, 1:500-506.
45. Knutson S.K., Warholic N.M., Wigle T.J., Klaus C.R., Allain C.J., Raimondi A., Porter Scott M., Chesworth R., Moyer M.P., Copeland R.A., et al. Durable tumor regression in genetically altered malignant rhabdoid tumors byinhibition of methyltransferase EZH2. Proc. Natl. Acad. Sci. USA 2013, 110:7922-7927.
46. Koga M., Ishiguro H., Yazaki S., Horiuchi Y., Arai M., Niizato K., Iritani S., Itokawa M., Inada T., Iwata N., et al. Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia. Hum. Mol. Genet. 2009, 18:2483-2494.
47. Kuwahara Y., Charboneau A., Knudsen E.S., Weissman B.E. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism. Cancer Res. 2010, 70:1854-1865.
48. Lee R.S., Stewart C., Carter S.L., Ambrogio L., Cibulskis K., Sougnez C., Lawrence M.S., Auclair D., Mora J., Golub T.R., et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J. Clin. Invest. 2012, 122:2983-2988.
49. Lessard J., Wu J.I., Ranish J.A., Wan M., Winslow M.M., Staahl B.T., Wu H., Aebersold R., Graef I.A., Crabtree G.R. An essential switch insubunit composition of a chromatin remodeling complex during neural development. Neuron 2007, 55:201-215.
50. Li X.S., Trojer P., Matsumura T., Treisman J.E., Tanese N. Mammalian SWI/SNF-a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. Mol. Cell. Biol. 2010, 30:1673-1688.
51. Li M., Zhao H., Zhang X., Wood L.D., Anders R.A., Choti M.A., Pawlik T.M., Daniel H.D., Kannangai R., Offerhaus G.J.A., et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat. Genet. 2011, 43:828-829.
52. Lickert H., Takeuchi J.K., Von Both I., Walls J.R., McAuliffe F., Adamson S.L., Henkelman R.M., Wrana J.L., Rossant J., Bruneau B.G. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 2004, 432:107-112.
53. Machida Y., Murai K., Miyake K., Iijima S. Expression of chromatin remodeling factors during neural differentiation. J. Biochem. 2001, 129:43-49.
54. McCabe M.T., Ott H.M., Ganji G., Korenchuk S., Thompson C., Van Aller G.S., Liu Y., Graves A.P., Della Pietra A., Diaz E., et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 2012, 492:108-112.
55. Medina P.P., Romero O.A., Kohno T., Montuenga L.M., Pio R., Yokota J., Sanchez-Cespedes M. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines. Hum. Mutat. 2008, 29:617-622.
56. Moloney F.J., Lyons J.G., Bock V.L., Huang X.X., Bugeja M.J., Halliday G.M. Hotspot mutation of Brahma in non-melanoma skin cancer. J. Invest. Dermatol. 2009, 129:1012-1015.
57. Morozov A., Lee S.J., Zhang Z.-K., Cimica V., Zagzag D., Kalpana G.V. INI1 induces interferon signaling and spindle checkpoint in rhabdoid tumors. Clin. Cancer Res. 2007, 13:4721-4730.
58. Nagl N.G., Zweitzig D.R., Thimmapaya B., Beck G.R., Moran E. The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest. Cancer Res. 2006, 66:1289-1293.
59. Nagl N.G., Wang X., Patsialou A., Van Scoy M., Moran E. Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J. 2007, 26:752-763.
60. Nikoloski G., Langemeijer S.M.C., Kuiper R.P., Knops R., Massop M., Tönnissen E.R.L.T.M., van der Heijden A., Scheele T.N., Vandenberghe P., de Witte T., et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat. Genet. 2010, 42:665-667.
61. Oike T., Ogiwara H., Tominaga Y., Ito K., Ando O., Tsuta K., Mizukami T., Shimada Y., Isomura H., Komachi M., et al. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1. Cancer Res. 2013, 73:5508-5518.
62. Oruetxebarria I., Venturini F., Kekarainen T., Houweling A., Zuijderduijn L.M.P., Mohd-Sarip A., Vries R.G.J., Hoeben R.C., Verrijzer C.P. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells. J. Biol. Chem. 2004, 279:3807-3816.
63. Park J.-H., Park E.-J., Lee H.-S., Kim S.J., Hur S.-K., Imbalzano A.N., Kwon J. Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction. EMBO J. 2006, 25:3986-3997.
64. Parsons D.W., Li M., Zhang X., Jones S., Leary R.J., Lin J.C.-H., Boca S.M., Carter H., Samayoa J., Bettegowda C., et al. The genetic landscape of the childhood cancer medulloblastoma. Science 2011, 331:435-439.
65. Phelan M.L., Sif S., Narlikar G.J., Kingston R.E. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol. Cell 1999, 3:247-253.
66. Ramirez-Carrozzi V.R., Braas D., Bhatt D.M., Cheng C.S., Hong C., Doty K.R., Black J.C., Hoffmann A., Carey M., Smale S.T. A unifying model for the selective regulation of inducible transcription by CpG islands andnucleosome remodeling. Cell 2009, 138:114-128.
67. Ramos P., Karnezis A.N., Craig D.W., Sekulic A., Russell M.L., Hendricks W.P.D., Corneveaux J.J., Barrett M.T., Shumansky K., Yang Y., et al. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat. Genet. 2014, 46:427-429.
68. Reisman D.N., Sciarrotta J., Wang W., Funkhouser W.K., Weissman B.E. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res. 2003, 63:560-566.
69. Reisman D.N., Sciarrotta J., Bouldin T.W., Weissman B.E., Funkhouser W.K. The expression of the SWI/SNF ATPase subunits BRG1 and BRM in normal human tissues. Appl. Immunohistochem. Mol. Morphol. 2005, 13:66-74.
70. Reisman D., Glaros S., Thompson E.A. The SWI/SNF complex and cancer. Oncogene 2009, 28:1653-1668.
71. Reyes J.C., Barra J., Muchardt C., Camus A., Babinet C., Yaniv M. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J. 1998, 17:6979-6991.
72. Roberts C.W., Galusha S.A., McMenamin M.E., Fletcher C.D., Orkin S.H. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc. Natl. Acad. Sci. USA 2000, 97:13796-13800.
73. Roberts C.W.M., Leroux M.M., Fleming M.D., Orkin S.H. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell 2002, 2:415-425.
74. Romero O.A., Setien F., John S., Gimenez-Xavier P., Gómez-López G., Pisano D., Condom E., Villanueva A., Hager G.L., Sanchez-Cespedes M. The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer. EMBO Mol. Med. 2012, 4:603-616.
75. Romero O.A., Torres-Diz M., Pros E., Savola S., Gomez A., Moran S., Saez C., Iwakawa R., Villanueva A., Montuenga L.M., et al. MAX inactivation in small cell lung cancer disrupts the MYC-SWI/SNF programs and is synthetic lethal with BRG1. Cancer Discov. 2014, 4:292-303.
76. Ronan J.L., Wu W., Crabtree G.R. From neural development to cognition: unexpected roles for chromatin. Nat. Rev. Genet. 2013, 14:347-359.
77. Sausen M., Leary R.J., Jones S., Wu J., Reynolds C.P., Liu X., Blackford A., Parmigiani G., Diaz L.A., Papadopoulos N., et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat. Genet. 2013, 45:12-17.
78. Shain A.H., Pollack J.R. The spectrum of SWI/SNF mutations, ubiquitous in human cancers. PLoS ONE 2013, 8:e55119.
79. Shen H., Powers N., Saini N., Comstock C.E.S., Sharma A., Weaver K., Revelo M.P., Gerald W., Williams E., Jessen W.J., et al. The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer. Cancer Res. 2008, 68:10154-10162.
80. Shi J., Whyte W.A., Zepeda-Mendoza C.J., Milazzo J.P., Shen C., Roe J.S., Minder J.L., Mercan F., Wang E., Eckersley-Maslin M.A., et al. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev. 2013, 27:2648-2662.
81. Singh A.P., Archer T.K. Analysis of the SWI/SNF chromatin-remodeling complex during early heart development and BAF250a repression cardiac gene transcription during P19 cell differentiation. Nucleic Acids Res. 2014, 42:2958-2975.
82. Strano S., Dell'Orso S., Di Agostino S., Fontemaggi G., Sacchi A., Blandino G. Mutant p53: an oncogenic transcription factor. Oncogene 2007, 26:2212-2219.
83. Strobeck M.W., Reisman D.N., Gunawardena R.W., Betz B.L., Angus S.P., Knudsen K.E., Kowalik T.F., Weissman B.E., Knudsen E.S. Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling. J. Biol. Chem. 2002, 277:4782-4789.
84. Tolstorukov M.Y., Sansam C.G., Lu P., Koellhoffer E.C., Helming K.C., Alver B.H., Tillman E.J., Evans J.A., Wilson B.G., Park P.J., Roberts C.W. Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters. Proc. Natl. Acad. Sci. USA 2013, 110:10165-10170.
85. Trouche D., Le Chalony C., Muchardt C., Yaniv M., Kouzarides T. RB and hbrm cooperate to repress the activation functions of E2F1. Proc. Natl. Acad. Sci. USA 1997, 94:11268-11273.
86. Van Houdt J.K.J., Nowakowska B.A., Sousa S.B., van Schaik B.D.C., Seuntjens E., Avonce N., Sifrim A., Abdul-Rahman O.A., van den Boogaard M.-J.H., Bottani A., et al. Heterozygous missense mutations inSMARCA2 cause Nicolaides-Baraitser syndrome. Nat. Genet. 2012, 44:445-449. S1.
87. van Oijen M.G.C.T., Slootweg P.J. Gain-of-function mutations in the tumor suppressor gene p53. Clin. Cancer Res. 2000, 6:2138-2145.
88. Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P., Davies H., Jones D., Lin M.-L., Teague J., et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011, 469:539-542.
89. Versteege I., Sévenet N., Lange J., Rousseau-Merck M.F., Ambros P., Handgretinger R., Aurias A., Delattre O. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998, 394:203-206.
90. Wang W., CÔté J., Xue Y., Zhou S., Khavari P.A., Biggar S.R., Muchardt C., Kalpana G.V., Goff S.P., Yaniv M., et al. Purification and biochemicalheterogeneity of the mammalian SWI-SNF complex. EMBO J. 1996, 15:5370-5382.
91. Wang X., Sansam C.G., Thom C.S., Metzger D., Evans J.A., Nguyen P.T., Roberts C.W. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex. Cancer Res. 2009, 69:8094-8101.
92. Wang K., Kan J., Yuen S.T., Shi S.T., Chu K.M., Law S., Chan T.L., Kan Z., Chan A.S.Y., Tsui W.Y., et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat. Genet. 2011, 43:1219-1223.
93. Wang X., Werneck M.B.F., Wilson B.G., Kim H.-J., Kluk M.J., Thom C.S., Wischhusen J.W., Evans J.A., Jesneck J.L., Nguyen P., et al. TCR-dependent transformation of mature memory phenotype Tcells in mice. J. Clin. Invest. 2011, 121:3834-3845.
94. Wang L., Zhao Z., Meyer M.B., Saha S., Yu M., Guo A., Wisinski K.B., Huang W., Cai W., Pike J.W., et al. CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis. Cancer Cell 2014, 25:21-36.
95. Wang X., Haswell J.R., Roberts C.W.M. Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer-mechanisms and potential therapeutic insights. Clin. Cancer Res. 2014, 20:21-27.
96. Watanabe R., Ui A., Kanno S., Ogiwara H., Nagase T., Kohno T., Yasui A. SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability. Cancer Res. 2014, 74:2465-2475.
97. Wiegand K.C., Shah S.P., Al-Agha O.M., Zhao Y., Tse K., Zeng T., Senz J., McConechy M.K., Anglesio M.S., Kalloger S.E., et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med. 2010, 363:1532-1543.
98. Wilson B.G., Roberts C.W.M. SWI/SNF nucleosome remodellers and cancer. Nat. Rev. Cancer 2011, 11:481-492.
99. Wilson B.G., Wang X., Shen X., McKenna E.S., Lemieux M.E., Cho Y.-J., Koellhoffer E.C., Pomeroy S.L., Orkin S.H., Roberts C.W.M. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell 2010, 18:316-328.
100. Wilson B.G., Helming K.C., Wang X., Kim Y., Vazquez F., Jagani Z., Hahn W.C., Roberts C.W.M. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation. Mol. Cell Biol. 2014, 34:1134-1144.
101. Witkowski L., Carrot-Zhang J., Albrecht S., Fahiminiya S., Hamel N., Tomiak E., Grynspan D., Saloustros E., Nadaf J., Rivera B., et al. Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat. Genet. 2014, 46:438-443.
102. Wong A.K.C., Shanahan F., Chen Y., Lian L., Ha P., Hendricks K., Ghaffari S., Iliev D., Penn B., Woodland A.-M., et al. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res. 2000, 60:6171-6177.
103. Wu J.I., Lessard J., Olave I.A., Qiu Z., Ghosh A., Graef I.A., Crabtree G.R. Regulation of dendritic development by neuron-specific chromatin remodeling complexes. Neuron 2007, 56:94-108.
104. Wu J.I., Lessard J., Crabtree G.R. Understanding the words of chromatin regulation. Cell 2009, 136:200-206.
105. You J.S., De Carvalho D.D., Dai C., Liu M., Pandiyan K., Zhou X.J., Liang G., Jones P.A. SNF5 is an essential executor of epigenetic regulation during differentiation. PLoS Genet. 2013, 9:e1003459.
106. Yu Y., Chen Y., Kim B., Wang H., Zhao C., He X., Liu L., Liu W., Wu L.M.N., Mao M., et al. Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell 2013, 152:248-261.
107. Zhang M., Chen M., Kim J.-R., Zhou J., Jones R.E., Tune J.D., Kassab G.S., Metzger D., Ahlfeld S., Conway S.J., Herring B.P. SWI/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development. Mol. Cell. Biol. 2011, 31:2618-2631.
108. Zheng P., Patel B., McMenamin M., Paprocki A.M., Schramm R.D., Nagl N.G., Wilsker D., Wang X., Moran E., Latham K.E. Expression of genes encoding chromatin regulatory factors in developing rhesus monkey oocytes and preimplantation stage embryos: possible roles in genome activation. Biol. Reprod. 2004, 70:1419-1427.